Pocket Program - CROI

CROI 2013 Session 49
1103 Attrition through Multiple Stages of HIV Care
in South Africa: A Challenge for Test-and-Treat
Matthew Fox* 1,2,3 and K Shearer 3
1 Ctr for Global Hlth and Devt, Boston Univ, MA, US;; 2 Boston Univ Sch of
Publ Hlth, MA, US;; and 3 Hlth Economics and Epidemiology Res Office,
Univ of the Witwatersrand, Johannesburg, South Africa
1104 Retention in Care up to ART Initiation within a
Decentralized HIV Program in South Africa:
The Critical Role of the First Clinic Visit
Melanie Plazy* 1,2 , R Dray-Spira 3 , J Orne-Gliemann 1,2 , F Dabis 1,2 ,
and M-L Newell 4
1 Univ Bordeaux, ISPED, INSERM U897, France;; 2 ISPED, INSERM
U897, Bordeaux, France;; 3 Epidemiology of Occupational and Social
Determinants of Hlth-Ctr for Res in Epidemiology and Population Hlth,
INSERM U1018, Villejuif, France;; and 4 Africa Ctr for Hlth and Population
Studies, Univ of KwaZulu-Natal, South Africa
1105 Co-enrollment of HIV + Family Members in Care
Is Associated with Improved Outcomes for Women
on ART: A Cohort Study
Landon Myer* 1 , J Duong 2 , Y Zhang 2 , E Abrams 3 , R Carter 3 ,
and MTCT-Plus Initiative
1 Univ of Cape Town, South Africa;; 2 Mailman Sch of Publ Hlth, Columbia
Univ, New York, US;; and 3 Intl Ctr for AIDS Care and Treatment Prgms,
Mailman Sch of Publ Hlth, Columbia Univ, New York, NY, US
1106 A Sampling-based Approach to Assessing
Patient-reported Barriers to Retention among
HIV + Patients on ART: East Africa
Elvin Geng* 1 , T Odeny 2 , L Rita 3 , A Nakiwogga-Muwanga 4 , M Bwana 5 ,
E Bukusi 6 , G Somi 3 , P Braitstein 7 , C Yiannoutsos 7 , J Martin 1 , and East
Africa Intl Epidemiologic Databases to Evaluate AIDS
1 Univ of California, San Francisco, US;; 2 Family AIDS Care and Ed Svcs,
Kisumu, Kenya;; 3 Natl AIDS Control Prgm, Dar es Salaam, Tanzania;;
4 Infectious Disease Inst, Kampala, Uganda;; 5 Mbarara Univ of Sci
and Tech, Uganda;; 6 Kenya Med Res Inst, Nairobi;; and 7 Indiana Univ,
Indianapolis, US
1107 Real-time HIV ART Adherence Monitoring
Predicts Loss of Viral Suppression and Subsequent
Resuppression: Rural Uganda
Jessica Haberer* 1,2 , C Muzoora 3 , P Hunt 4 , J Martin 4 , M Siedner 1,2 ,
and D Bangsberg 1,2,3
1 Massachusetts Gen Hosp, Boston, US;; 2 Harvard Med Sch, Boston, MA,
US;; 3 Mbarara Univ of Sci and Tech, Uganda;; and 4 Univ of California,
San Francisco, US
b Wednesday, 1:30-2:30 pm; Ballroom 1-2
Session 49–Themed Discussion
(see Session 137 on Tuesday for corresponding Poster Abstracts)
Inflammatory Biomarkers, Microparticles, and
Clinical Outcomes in HIV
Discussants:
Tricia Burdo, Boston Coll, MA, US
Esteban Martinez, Hosp Clin, Barcelona, Spain (invited)
788 Inflammatory Cytokines and Mortality in a Cohort
of HIV + Patients with Alcohol Problems
Daniel Fuster* 1 , D Cheng 1,2 , E Quinn 3 , K Armah 4 , R Saitz 1 ,
M Freiberg 5 , J Samet 1 , and J Tsui 1
1 Boston Med Ctr and Boston Univ Sch of Med, MA, US;; 2 Boston Univ Sch of
Publ Hlth, MA, US;; 3 Data Coordinating Ctr, Boston Univ Sch of Publ Hlth,
MA, US;; 4 Univ of Pittsburgh Grad Sch of Publ Hlth, PA, US;; and 5 Univ of
Pittsburgh, PA, US
789 Tissue Factor Microparticles among HIV + Persons
Are Reduced with ART and Associated with D-dimer
Levels after Treatment
Jason Baker* 1,2 , K Huppler Hulsiek 1 , R Bradford 3 , R Prosser 1,2 , R Tracy 4 ,
and N Key 3
1 Univ of Minnesota, Minneapolis, US;; 2 Hennepin County Med Ctr,
Minneapolis, MN, US;; 3 Univ of North Carolina at Chapel Hill, US;;
and 4 Univ of Vermont, Burlington, US
790 Soluble Markers of Inflammation and Coagulation,
but Not T Cell Activation, Predict Non-AIDS-defining
Events during Suppressive ART
Allan Tenorio* 1 , E Zheng 2 , R Bosch 2 , S Deeks 3 , B Rodriguez 4 ,
S Krishnan 2 , P Hunt 3 , C Wilson 5 , M Lederman 4 , A Landay 1 , and ACTG
1 Rush Univ Med Ctr, Chicago, IL, US;; 2 Harvard Sch of Publ Hlth, Boston,
MA, US;; 3 San Francisco Gen Hosp and Univ of California, San Francisco,
US;; 4 Case Western Reserve Univ Sch of Med, Cleveland, OH, US;; and
5 Univ of Colorado Hosp, Aurora, US
791 Inflammation and Coagulation Markers Are
Predictive of Anemia in ARV-treated HIV Disease
Alvaro Borges* 1 , J Weitz 2 , G Collins 3 , J Baker 3,4 , Y Levy 5 , R Davey 6 ,
A Phillips 7 , J Neaton 3 , J Lundgren 1 , S Deeks 8 , for INSIGHT SILCAAT
Study Group
1 Copenhagen HIV Prgm and Rigshospitalet, Denmark;; 2 Thrombosis
and Atherosclerosis Res Inst, Hamilton, Canada;; 3 Univ of Minnesota,
Minneapolis, US;; 4 Hennepin County Med Ctr, Minneapolis, MN, US;;
5 Assistance Publ-Hosp de Paris, INSERM U955, Univ Paris 12, Creteil,
France;; 6 NIAID, NIH, Bethesda, MD, US;; 7 Univ Coll London Med Sch,
UK;; and 8 Univ of California, San Francisco, US
792 Osteoprotegerin and Receptor Activator of Nuclear
Factor Kappa Ligand Are Associated with
Subclinical Coronary Atherosclerosis: Multicenter
AIDS Cohort Study
Kerunne Ketlogetswe* 1 , W Post 1,2 , X Li 2 , L Jacobson 2 , F Palella 3 ,
J Margolick 2 , L Kingsley 4 , M Witt 5 , M Budoff 5 , T Brown 1,2 , and Multictr
AIDS Cohort Study
1 Johns Hopkins Univ Sch of Med, Baltimore, MD, US;; 2 Johns Hopkins Univ
Bloomberg Sch of Publ Hlth, Baltimore, MD, US;; 3 Northwestern Univ
Feinberg Sch of Med, Chicago, IL, US;; 4 Univ of Pittsburgh Grad Sch of
Publ Hlth, PA, US;; and 5 Harbor UCLA Med Ctr, Torrance, CA, US
Program 21
Wednesday
March 6 Oral Sessions